News, insights and education shaped by experts in pharma and biotech. Fierce Life Sciences offers a full suite of ... Visit Fierce Pharma. Fierce-Biotech.
Dec 13, 2021 · Korro Bio rings in new year with $116M for OPERA RNA editing. Ticket sales for Korro Bio's second financing round landed at $116 million as the biotech builds up funds to bankroll its RNA editing ...
Fierce Pharma covers the pharma waterfront, from late-stage drug development through the entire lifecycle—tracking regulatory approvals, payer negotiations, ...
Read the latest biotechnology articles on biotech industry leaders, emerging biotech companies, FDA decisions, VC deals, and other biotech industry news.
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products ...
10.01.2022 · Fierce Pharma will be covering the day's biggest news at it happens. Check back here for updates, and catch Fierce Biotech's coverage here . …
Jan 04, 2022 · Visit FiercePharma for pharma industry news on big pharma, FDA decisions, patents, pharmaceutical marketing, generic drugs, and other pharma news.
06.12.2021 · Lessons from evolution: from innate immunity to novel cancer immunotherapies. In recent years, we’ve seen remarkable progress in combatting devastating cancers, with the rise of immunotherapies ...
13.12.2021 · Korro Bio rings in new year with $116M for OPERA RNA editing. Ticket sales for Korro Bio's second financing round landed at $116 million as the biotech builds up funds to bankroll its RNA editing ...
news, the recap of. @JNJNews. new CEO Juaquin Duato's conversation and more. fiercepharma.com. #JPM22, Day 1: Bristol Myers Squibb's blockbuster losses of ...
FiercePharma The Pharma Industry Daily Monitor Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Pharma as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D.